Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody. The synergistic combination of the conjugates and biomolecules confer desired functions, which otherwise are difficult to achieve with individual counterparts. These functionalities offer increased membrane permeability, target specificity, circulation time and enhanced pharmacokinetic properties. It is interesting to highlight that when the modification with conjugates lead to detection (direct / indirect) in bioimaging and immunoassays, bioconjugation is also referred to as biomolecule labeling.
Presently, industry stakeholders employ various labeling approaches (fluorescent labeling and isotopic labeling) for protein profiling in order to quantify the compounds, and monitor and visualize the biological processes. Over the last couple of years, the pharmaceutical industry has also witnessed the utility of these complex entities across several application areas, such as development of conjugated drug therapeutics, drug delivery systems, disease diagnosis, invention of diagnostic tools, and high-throughput screening. Presently, a number of players across the globe are actively engaged in providing efficient antibody conjugation services for research purposes. Further, given the rising demand for conjugated biomolecules in the field of research and development, the conjugation and labeling services market is anticipated to witness substantial growth in the foreseen future.
Key Market Insights
The Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Distribution by Type of Molecule Supported (Proteins, Peptides, Small Molecules, Antibodies and Other Molecules), Type of Molecular Conjugate / Label (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes and Other Molecular Conjugates / Labels), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period. Further, it highlights the efforts of several stakeholders engaged in this rapidly emerging domain of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.
Need for Outsourcing Conjugation and Labeling Operations to Service Providers
A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. The service providers tend to be equipped with established methodologies, along with a wide range of reagent systems and conjugates required for the chemical modification of different biomolecules. These factors together will be responsible for market growth through increased outsourcing of protein labeling, antibody labeling and antibody conjugation services to the CROs.
Current Landscape of the Conjugation and Labeling Services Market
The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Overall, the market seems to be well-fragmented, featuring the presence of very large, large, mid-sized and small companies, which have the required expertise to offer bioconjugation services across different types of biomolecules, such as proteins, antibodies, peptides and small molecules. It is worth mentioning that 78% of the service providers offer antibody conjugation with haptens; notable examples (which have also been captured in this report) include AAT Bioquest, Abzena, Fina Biosolutions, Life Tein, ProSci, Synaptic Systems and ViroGen.
Segment Analysis - Antibody Conjugation Services are the most sought
Custom antibody conjugation for research purposes is the most sought service in this market. Some of the antibody conjugation services offered by the companies include conjugation with HRP conjugation, Biotin Conjugation and Fluorescent labeling services. Antibody labeling, which is also known as antibody conjugation, involves conjugating a tag to an antibody. In this report, we have captured all the antibody conjugation services that are relevant to research / diagnostic applications.
Segment Analysis - Fluorescent Tags are preferred tool for Biomolecule Labeling
Fluorescent tags are widely employed in the field of proteomics in order to detect the location of protein and quantity of the protein. These also lead to identification of conformational changes during protein complex formation and tracking the biological processes. Some of the companies also offer tagging of fluorescent probes with antibodies and peptides for research purposes.
Regional Analysis - North America to hold the Largest Share
Over the past few years, there has been a steady increase in the companies offering protein labeling, peptide labeling, small molecule conjugation and antibody conjugation services. Of these, majority of the bioconjugation service providers are based in North America.
Trend Analysis - Service Providers evolving to meet the market demand
Various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. The field is continuously evolving; stakeholders are actively participating in events (webinars / conferences / seminars / meetings / symposiums / summits) related to bioconjugation and labeling of biomolecules. These events are likely to provide the necessary platform for companies to present their ideas, innovative bioconjugation methodologies / techniques and discuss various applications of bioconjugates to a wider audience. Given the inclination towards cutting-edge technologies, along with innovative approaches to tailor the biomolecules, we believe that the conjugation and labeling services market is likely to evolve at a rapid pace, during the forecast period 2023-2035.
Scope of the Report
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments.
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report features:
- An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
- A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Further, the chapter concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
- A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
- A company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
- Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
- A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
- An in-depth analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
- A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with conjugation and labeling services market, over the forecast period. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market growth.
The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain.
The report features detailed transcripts of interviews held with the following industry stakeholders:
- Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research)
- Vishal Rai (Founder, Plabeltech)
- Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing)
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2BScientific
- AAPPTec
- AAT Bioquest
- Ab Biotechnology
- AbBioSci
- Abbiotec
- Abcam
- Abcepta
- AbClon
- Abclonal
- Abcore
- Abeomics
- ABI Scientific
- Abingdon Health
- Abnova
- Absea Biotechnology
- Absolute Antibody
- Abzena
- ACROBiosystems
- Activotec
- Adaltis
- Advanced Peptides
- Affigenix Biosolutions
- Affinity Biologicals
- Affinity Biosciences
- Affinity Life Sciences
- Ainnocence
- AIVD Biotech
- AlexoTech
- Almac
- Alomone Labs
- Alpha Diagnostic
- AltaBioscience
- AMSBIO
- AnaSpec
- Antagene
- AnteoTech
- Antibodies
- antibodies-online
- Antibody Research
- Arbor Assays
- Arista Biologicals
- ARVYS Proteins
- Ascension
- Aurigene Pharmaceutical Services
- Aurion
- Aurora Biolabs
- AURUM Pharmatech
- Aves Labs
- Aviva Systems Biology
- Bachem
- BBI Solutions
- Bethyl Laboratories (a subsidiary of Fortis Life Sciences)
- Bhat Bio-tech
- Bicycle Therapeutics
- Bio Basic
- BioActs
- Biobest
- Bioclone
- BioCores
- BioEastern
- BioGenes
- BIOHUB INTERNATIONAL
- BioLegend
- Biologics International
- Biomatik
- BioNova Pharmaceuticals
- Biorbyt
- BiOrion Technologies
- BIOSYNTAN
- Biosynth
- Bio-Synthesis
- BioTag
- Biotech Desk
- BioTeZ
- BioVision
- BIOZOL
- BOC Sciences
- Boster Biological Technology
- BPS Bioscience
- BrickBio
- BroadPharm
- Brookwood Biomedical
- Calico Biolabs (a subsidiary of Abcam)
- Cambridge Innovation Institute
- CanPeptide
- Capra Science
- Caprico Biotechnologies
- CARBOGEN AMICS
- CASLO
- Cayman Chemical
- CD Bioparticles
- celares
- Cell Signalling Technology
- CellMosaic
- Centre national de la recherche scientifique (CNRS)
- Charles River Laboratories
- Chayon Laboratories
- ChemPartner
- ChemPep
- CHI Scientific
- ChinaPeptides
- ChromoTek (a subsidiary of Proteintech)
- Cisbio (a subsidiary of PerkinElmer)
- Clementia Biotech
- Click Biosystems
- CliniSciences
- Coherent Biopharma
- Columbia Biosciences
- CordenPharma
- CortecNet
- Covalab
- CPC Scientific
- CreaGen
- Creative Biolabs
- Creative BioMart
- Creative Diagnostics
- Creative Enzymes
- Creative Peptides
- Creative Proteomics
- CRELUX
- C-Six Labs
- Curia
- Curida Diatec
- Cygnus Technologies
- Cytiva
- Cytodiagnostics
- Denovo Biolabs
- Denovo Biotechnology
- Designer BioScience
- Detai Bio-Tech
- Diatheva
- Drug Delivery Experts (acquired by Pace Analytical Services)
- Elabscience
- emp Biotech
- Enzo Life Sciences
- ETH Zurich
- Eurogentec
- Exeris
- exonbio
- Expedeon (a subsidiary of Abcam)
- Explora Biotech
- EZBiolab
- Fagus Antibody Services
- Fina Biosolutions
- Fleet Bioprocessing
- Fortis Life Sciences
- FUJIFILM Wako Pure Chemical
- Full Moon BioSystems
- Fusion Pharmaceuticals
- Future Diagnostics
- G&P Biosciences
- G-Biosciences
- GCC Biotech
- GeneDireX
- Genei Laboratories
- Genemed Synthesis
- GENEPEP
- GeneTex
- GeNext Genomics
- Genosphere Biotechnologies
- Genovis
- GenPro Biotech
- GenScript
- GenxBio
- German Research Products
- Gifford Bioscience
- Giotto Biotech
- GL Biochem
- GlycoT Therapeutics
- Glykos
- Goodwin Biotechnology
- Gyros Protein Technologies (a subsidiary of Mesa Laboratories)
- Hanyang University
- Healstone Biotech
- HUABIO
- HumanZyme (a subsidiary of Proteintech)
- Hypermol
- Immuno-Biological Laboratories
- INDIGO Biosciences
- InnoCare Pharma
- InnoPep
- Innova Biosciences
- Institut de Biologie Structurale
- Institute of Pharmacology and Structural Biology
- InVivo BioTech Services
- IRBM
- Isca Biochemicals
- Jackson ImmunoResearch
- Jena Bioscience
- JPT Peptide Technologies
- KareBay Biochem
- Kementec
- Kerafast
- Kinexus Bioinformatics
- KMD Bioscience
- Krishgen Biosciences
- KTH Royal Institute of Technology
- Kunming Institute of Botany
- Kyungpook Chonnam National Hospital
- Lab Bioreagents
- LabCorp
- Labospace
- LakePharma
- LAMPIRE Biological Laboratories
- Leadgene Biomedical
- Leading Biology
- Lehigh University
- Leinco Technologies
- Levena Biopharma
- LGC
- LifeTein
- Lonza
- LifeSpan BioSciences (LSBio)
- LubioScience
- Mabtech
- Macrocyclics
- Maliba Pharmacy College
- MBL International
- MedChemExpress
- Medicinal Chemistry Pharmaceutical
- MedKoo Biosciences
- Merck KGaA
- Mesa Laboratories
- Meso Scale Diagnostics
- metabion
- Microcoat Biotechnologie
- Mimotopes
- Molnova
- MuseChem
- nanoComposix
- Nanocs
- NanoHybrids
- Nanoimmunetech
- NeoScientific
- NJ Bio
- Nordic BioSite
- NOVA School of Science and Technology
- Novatein Biosciences
- NovoPro
- Novoprotein Scientific
- Novus Biologicals
- Ohio Peptide
- Oncomedics
- Ontores Biotechnologies
- OriGene Technologies
- OriMAbs
- Otto Chemie
- Pacific Immunology
- PATH
- Pepceuticals
- PeproTech
- Pepscan
- Peptide 2.0
- Peptide Institute
- Peptide Protein Research
- Peptide Therapeutics Foundation
- PeptidePharma
- PerkinElmer
- Phoenix Pharmaceuticals
- piCHEM
- Plabeltech
- PolyPeptide
- PPD
- Prayaga Scientific Laboratories
- Precision BioLogic
- Primm Biotech
- Profacgen
- ProSci
- Protein One
- Protein Ark
- Proteintech
- ProteoGenix
- Proteos
- Prudue University
- PurMabiologics
- QED Bioscience
- Qognit
- R&D Systems
- RayBiotech Life
- RD-Biotech
- RevMAb Biosciences
- Rockland Immunochemicals
- rPeptide
- RS Synthesis
- RWJBarnabas Health
- SanBio
- SB-PEPTIDE
- SBS Genetech
- SCHOTT MINIFAB
- Scotia Biologics
- Seoul National University
- SeraCare Life Sciences
- Seramun Diagnostica
- Shikhar Biotech
- ShineGene Bio-Technologies
- Singzyme
- Sino Biological
- South Bay Bio
- SouthernBiotech
- Space Peptides
- Standard BioTools
- Steffens-Biotec
- Swiss Biotech Association
- Syd Labs
- Synaptic Systems
- Synbio Technologies
- Syngene
- SynPeptide
- Tata Institute of Fundamental Research
- Telix Pharmaceuticals
- The Antibody Company
- The Michael J. Fox Foundation
- The University of British Columbia
- Thermo Fisher Scientific
- Toxikon
- trenzyme
- TriLink BioTechnologies
- UNC Lineberger Comprehensive Cancer Center
- University of Georgia
- University of Bologna
- University of Eastern Finland
- University of Florence
- University of Iceland
- University of Louisville
- University of Prince Edward Island
- USV
- University of Utah
- Vector Laboratories
- Viewpoint Molecular Targeting
- ViroGen
- World Academy of Science, Engineering and Technology
- WuXi Biologics
- WuXi STA
- Xaia Custom Peptides
- Xynomic Pharmaceuticals
- YCharOS
- Yonsei University
- YuRoGen Biosystems
Methodology
LOADING...